YORVIPATH

palopegteriparatide · Ascendis Pharma, Endocrinology, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for YORVIPATH, covering 2024-08-09 to 2026-08-03. Get the full timeline:

Most recent: FDA Approved: YORVIPATH — Supplemental Application (Ascendis Pharma, Endocrinology, Inc.)